Psychedelics Today29 Nov 2024

PT569 – Is Cannabis a Psychedelic? Exploring the Science of Indoles, Interprening, and Intention, with Max Montrose

In this episode, Victoria interviews Max Montrose: Founder of the Trichome Institute, a company offering online courses and certifications on cannabis.

Montrose explores the scientific and sensory aspects of cannabis, diving into the role of the aromatic compound, indole, and how the fresher and more aromatic (usually pungent) the flower is, the higher chance for having a more psychedelic experience. He dives into ways to maximize the psychedelic nature of cannabis, largely through "interprening," which is his method for learning about a plant's effects from smelling buds, measuring your sense of sensation and where you feel the smell is hitting you. And he talks a lot about intention and how the power of a cannabis experience can be determined by the reverence you have for the plant and the intention you put behind each inhale: It is a "total reflection of how much you care."

He also discusses:

The range of cannabis effects: how it can be just weed – something mindlessly smoked all day with a slight numbing effect – or an incredibly powerful, life-changing experience
The importance of skillset being added to the concept of set and setting: the skills you have (and can practice) for helping you create your own setting to get through a tough time
Issues with the legal cannabis industry about accuracy of strains, shelf life, and the ability to smell the product
The lack of money in cannabis research: Why is no one funding research into indole chemistry?
Why indica and sativa are not accurate terms, and how aroma is more of a factor than we realize

and more!

For links, head to the show notes page.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(774)

PT 656 - Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

Denver mushroom decriminalization changed the national conversation around psilocybin access, personal use, and grassroots psychedelic reform. In this episode of Psychedelics Today, Joe Moore speaks w...

11 Mai 1h 43min

PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium

Aspen Psychedelic Symposium is the focus of this conversation with Martha Hammel of the Aspen Psychedelic Resource Center and Tasia Poinsatte of Healing Advocacy Fund. They join Joe Moore to discuss t...

8 Mai 54min

PT 654 - Erica Rex - Seeing What Is There

Seeing What Is There is at the center of this conversation with journalist and author Erica Rex, who joins Joe Moore to discuss her book Seeing What Is There: My Search for Sanity in the Psychedelic E...

23 Apr 1h 20min

PT 653 - Dr. Michael Alpert and Peter Alberding - ALS, Existential Distress, and Ketamine Therapy

ALS and ketamine therapy are at the center of this conversation with psychiatrist Dr. Michael Alpert and Peter Alberding, who was diagnosed with ALS in late 2023. Alpert is a Boston-area psychiatrist ...

16 Apr 1h 19min

PT 652 - Esme Dark - Psychedelics, Somatics and the Shadow

Dr. Esme Dark joins Kyle Buller for a conversation on psychedelic therapy, somatic psychotherapy, and shadow work. Based in Australia, Dark is a clinical psychologist, somatic psychotherapist, and psy...

25 Mar 1h 14min

PT 651 - Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

MAPS co-executive directors Betty Aldworth and Ismail Ali join Psychedelics Today to talk about leading one of the most visible organizations in the psychedelic field during a period of transition. Th...

19 Mar 1h 22min

PT 650 - Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

Jen Davenport joins Psychedelics Today to interview co-founder Joe Moore about the growth of Psychedelics Today, the broader psychedelic ecosystem, and how professionals are beginning to engage with p...

9 Mar 1h 6min

PT 649 - Melissa Lavasani and Jay Kopelman

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization...

19 Feb 1h 10min